These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31777870)

  • 21. Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors.
    Yang S; Tang Z; Hu C; Zhang D; Shen N; Yu H; Chen X
    Adv Mater; 2019 Mar; 31(11):e1805955. PubMed ID: 30680816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-accelerating H
    Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z
    Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
    J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploiting the Inherent Photophysical Properties of the Major Tirapazamine Metabolite in the Development of Profluorescent Substrates for Enzymes That Catalyze the Bioreductive Activation of Hypoxia-Selective Anticancer Prodrugs.
    Shen X; Laber CH; Sarkar U; Galazzi F; Johnson KM; Mahieu NG; Hillebrand R; Fuchs-Knotts T; Barnes CL; Baker GA; Gates KS
    J Org Chem; 2018 Mar; 83(6):3126-3131. PubMed ID: 29461834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
    Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
    Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
    Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
    Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
    Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
    [No Abstract]   [Full Text] [Related]  

  • 28. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
    Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
    Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
    Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide-releasing platinum(IV) prodrug efficiently inhibits proliferation and metastasis of cancer cells.
    Dai Y; Zhu Y; Cheng J; Shen J; Huang H; Liu M; Chen Z; Liu Y
    Chem Commun (Camb); 2020 Nov; 56(90):14051-14054. PubMed ID: 33103676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A platinum(iv) prodrug to defeat breast cancer through disrupting vasculature and inhibiting metastasis.
    Guo Y; Zhang S; Yuan H; Song D; Jin S; Guo Z; Wang X
    Dalton Trans; 2019 Mar; 48(11):3571-3575. PubMed ID: 30793153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
    Yang B; Keshelava N; Anderson CP; Reynolds CP
    Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer cell membrane-coated C-TiO
    Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X
    Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction.
    Li Y; Dang J; Liang Q; Yin L
    Biomaterials; 2019 Jul; 209():138-151. PubMed ID: 31034982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.
    Reshetnikov V; Arkhypov A; Julakanti PR; Mokhir A
    Dalton Trans; 2018 May; 47(19):6679-6682. PubMed ID: 29708261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel hypoxia-targeting Pt(iv) prodrugs.
    Xu Z; Zhao J; Gou S; Xu G
    Chem Commun (Camb); 2017 Mar; 53(26):3749-3752. PubMed ID: 28303266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precise gliomas therapy: Hypoxia-activated prodrugs sensitized by nano-photosensitizers.
    Zhang H; Shi C; Han F; Li M; Ma H; Sui R; Long S; Sun W; Du J; Fan J; Piao H; Peng X
    Biomaterials; 2022 Oct; 289():121770. PubMed ID: 36075142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
    Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
    Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
    Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
    Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dual-response drug delivery system with X-ray and ROS to boost the anti-tumor efficiency of TPZ
    Han P; Zhang L; Fu Y; Fu Y; Huang J; He J; Ni P; Khan T; Jiao Y; Yang Z; Zhou R
    Nanoscale; 2022 Dec; 15(1):237-247. PubMed ID: 36472214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.